TY  - GEN 
AU  - Hierro Bujalance, Carmen
AU  - Infante-Garcia, Carmen
AU  - Marco delgado, Ángel José del
AU  - Herrera, Marta
AU  - Carranza Naval,  María José
AU  - Suarez, Javier
AU  - Alves Martinez, Pilar
AU  - Lubián López, Simón Pedro
AU  - García Alloza, Mónica
A4  - Biomedicina, Biotecnología y Salud Pública
A4  - Materno-Infantil y Radiología
PY  - 2020
SN  - 1758-9193
UR  - http://hdl.handle.net/10498/22860
AB  - Background Both Alzheimer's disease (AD) and type 2 diabetes (T2D) share common pathological features including inflammation, insulin signaling alterations, or vascular damage. AD has no successful treatment, and the close relationship between both...
LA  - eng
PB  - BMC
KW  - Alzheimer’s disease
KW  - Type 2 diabetes
KW  - Amyloid-β
KW  - Hemorrhage
KW  - Microglia
KW  - Tau
KW  - Cognition
KW  - Empagliflozin
TI  - Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes
DO  - 10.1186/s13195-020-00607-4
ER  -